Kirk Tanner, PhD
KIRK TANNER, PhD, an oncology research leader with 20 years of experience in drug discovery and development, has been named as the new Chief Scientific Officer of the National Brain Tumor Society (NBTS).
In this role, Dr. Tanner will lead the Society’s research programs team in the creation and execution of initiatives that aim to develop new treatments. He will engage stakeholders from across the brain tumor landscape in the NBTS research programs. ■